LifeTech Scientific

LifeTech Scientific Stock-Based Compensation

The Stock-Based Compensation (SBC) of LifeTech Scientific (1302.HK) as of Nov 13, 2026 is 259.86 M CNY. In the previous year, Stock-Based Compensation (SBC) was 133.38 M CNY — a change of 94.83% (higher).

Stock-Based Compensation

259.86 MCNY

YoY

94.83%

Last updated:

Stock-Based Compensation (SBC) of LifeTech Scientific is 2025 259.86 M CNY. Stock-Based Compensation (SBC) of LifeTech Scientific was 2024 133.38 M CNY. It decreases by 94.83% higher compared to the previous year.

The LifeTech Scientific Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2018
70.13 M CNY
Jan 1, 2019
146.46 M CNY
Jan 1, 2020
179.19 M CNY
Jan 1, 2021
22.97 M CNY
Jan 1, 2022
72.99 M CNY
Jan 1, 2023
131.31 M CNY
Jan 1, 2024
133.38 M CNY
Jan 1, 2025
259.86 M CNY
The LifeTech Scientific Stock-Based Compensation history
YEARStock-Based CompensationYoY
259.86 MCNY+94.83%
133.38 MCNY+1.57%
131.31 MCNY+79.91%
72.99 MCNY+217.81%
22.97 MCNY-87.18%
179.19 MCNY+22.35%
146.46 MCNY+108.83%
70.13 MCNY+566.50%
10.52 MCNY-59.33%
25.87 MCNY+9.21%
23.69 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LifeTech Scientific Stock analysis

What does LifeTech Scientific do? LifeTech Scientific Corp is a leading company in the field of medical technology. The company was founded in 1999 in Beijing, China and has since become a global provider of medical products and solutions. LifeTech Scientific Corp has offices in the USA, Europe, Asia, and Africa and is listed on the Hong Kong Stock Exchange. The business model of LifeTech Scientific Corp is based on innovative medical solutions and products for cardiology and other medical specialties. The company aims to improve treatment options for patients and equip doctors with the best tools and technologies to provide the best diagnosis and treatment options. LifeTech Scientific Corp offers a wide range of products and solutions including diagnostic devices, implantable devices, surgical devices, and accessories. These products can be used in various medical specialties such as cardiology, vascular surgery, neurology, and intensive care. Cardiology is one of the key areas of LifeTech Scientific Corp. The company offers a wide range of products focused on treating heart conditions such as coronary artery disease, heart failure, and arrhythmias. This includes implantable cardiac devices such as Implantable Cardiac Defibrillators (ICDs) and pacemakers used to treat rhythm disorders. LifeTech Scientific Corp's devices are very advanced and provide patients with an excellent quality of life. In addition to cardiology, LifeTech Scientific Corp also offers devices and solutions for other medical specialties. In the field of neurology, for example, the company provides devices for monitoring brain activity and treating epilepsy. In vascular surgery, LifeTech Scientific Corp offers devices for diagnosing and treating aneurysms and narrowing of blood vessels. In intensive care, the company provides devices for ventilation and patient monitoring. The history of LifeTech Scientific Corp is characterized by continuous growth and the development of new products and solutions. In recent years, the company has built strategic partnerships with leading medical institutions and research facilities around the world to advance the development of new technologies and products. Overall, LifeTech Scientific Corp is now one of the leading companies in the field of medical technology, offering innovative solutions for a range of medical specialties. The company is committed to improving patients' quality of life and providing doctors with the best tools and technologies to ensure the best possible treatment. LifeTech Scientific is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LifeTech Scientific stock

Stock-Based Compensation (SBC) of LifeTech Scientific is 259.86 M CNY in 2025.

Stock-Based Compensation (SBC) of LifeTech Scientific changed from 133.38 M CNY to 259.86 M CNY, representing a 94.83% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) LifeTech Scientific since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s LifeTech Scientific historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — LifeTech Scientific

All Key Metrics — LifeTech Scientific